[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100567945":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":29,"centralContacts":33,"locations":38,"responsibleParty":53,"collaborators":25,"id":55,"slug":56,"hasResults":57,"nctId":58,"briefTitle":59,"officialTitle":60,"acronym":25,"eligibilityCriteria":61,"healthyVolunteers":57,"sex":62,"minAge":63,"maxAge":25,"enrollmentInfo":64,"targetDuration":25,"studyType":67,"phases":68,"briefSummary":70,"conditions":71,"keywords":74,"overallStatus":41,"whyStopped":25,"lastUpdateSubmitDate":79,"lastUpdatePostDateStruct":80,"startDateStruct":83,"completionDateStruct":85,"leadSponsor":87,"locationsCount":88},{"fullName":5,"class":6},"National Taiwan University Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Focused Extracorporeal Shock Wave","EXPERIMENTAL","Participants in this arm will receive focused Extracorporeal Shock Wave Therapy (ESWT) targeting four specific muscles: subscapularis, pectoralis major, latissimus dorsi, and teres major muscles. Each muscle will receive 1,000 shockwave shots per session, accumulating to a total of 4,000 shots across all targeted muscles in each session. The treatment will be administered twice a week for two consecutive weeks, resulting in a total of four treatment sessions.",[13],"Device: focused extracorporeal shock wave therapy (ESWT)",{"label":15,"type":16,"description":17,"interventionNames":18},"Placebo-Controlled Shockwave Therapy","PLACEBO_COMPARATOR","Participants in this arm will receive placebo-controlled focused ESWT, mirroring the treatment protocol of the experimental group but without the application of active shockwaves.",[13],[20,26],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DEVICE","focused extracorporeal shock wave therapy (ESWT)","The focused shockwaves are directed at the affected muscles in the upper limb, specifically targeting the subscapularis, pectoralis major, latissimus dorsi, and teres major muscles.",[9],null,{"type":21,"name":22,"description":27,"armGroupLabels":28,"otherNames":25},"Placebo shockwave therapy directed at subscapularis, pectoralis major, latissimus dorsi, and teres major muscles.",[15],[30],{"name":31,"affiliation":5,"role":32},"Shu-mei Yang, MD","PRINCIPAL_INVESTIGATOR",[34],{"name":31,"role":35,"phone":36,"phoneExt":25,"email":37},"CONTACT","0972653675","b99401109@gmail.com",[39],{"facility":40,"status":41,"city":42,"state":25,"zip":25,"country":43,"countryCode":44,"cosmosGeoPoint":45,"geoPoint":50,"contacts":51},"Department of Physical Medicine & Rehabilitation , National Taiwan University Hospital","RECRUITING","Taipei","Taiwan","TW",{"type":46,"coordinates":47},"Point",[48,49],121.52639,25.05306,{"lat":49,"lon":48},[52],{"name":31,"role":35,"phone":36,"phoneExt":25,"email":37},{"type":54,"investigatorFullName":25,"investigatorTitle":25,"investigatorAffiliation":25,"oldNameTitle":25,"oldOrganization":25},"SPONSOR","100567945","sirs-eswt-trial-shoulder-internal-rotator-spasticity-trial-treated-with-extracorporeal-shock-wave-therapy-trial-100567945",false,"NCT06674785","SIRS-ESWT Trial: Shoulder Internal Rotator Spasticity Trial Treated With Extracorporeal Shock Wave Therapy Trial","Effects of Extracorporeal Shock Wave Therapy on Shoulder Internal Rotator Spasticity in Post-Stroke Patients: A Randomized Controlled Trial","Inclusion Criteria:\n\n* Patients aged 18 years or older with unilateral cerebral stroke.\n* Restricted passive external rotation of the spastic shoulder by more than 20 degrees.\n* A Modified Ashworth Scale score of 1 or higher for shoulder internal rotator spasticity.\n* Stable medical condition and vital signs.\n* Clear consciousness, able to follow instructions.\n\nExclusion Criteria:\n\n* History of two or more strokes, traumatic brain injury, brain tumors, or other cerebral disorders.\n* Coexisting central nervous system disorders (e.g., spinal cord injury, Parkinson's disease) or other musculoskeletal conditions affecting muscle tone assessment.\n* Ineligibility for shock wave intervention due to malignancies, coagulation disorders, localized infections, or presence of a pacemaker.\n* Prior shock wave intervention or botulinum toxin injection for post-stroke spasticity within the past three months.\n* Inability to participate in interventions or functional assessments due to cognitive, consciousness, or language impairments.","ALL","18 Years",{"count":65,"type":66},40,"ESTIMATED","INTERVENTIONAL",[69],"NA","Extracorporeal shock wave therapy (ESWT) has shown potential in reducing post-stroke limb spasticity. This study aims to evaluate the efficacy of focused ESWT on shoulder internal rotator spasticity in post-stroke patients.",[72,73],"Stroke","Muscle Spasticity",[75,76,77,78],"stroke","spasticity","shock wave","shoulder","2025-07-27",{"date":81,"type":82},"2025-07-29","ACTUAL",{"date":84,"type":82},"2025-07-23",{"date":86,"type":66},"2027-12-31",{"name":5,"class":6},1]